Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of reviewing and recommending yearly updates to the COVID-19

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.

The FDA told Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines to include additional safety data about the risk of myocarditis in young men. ( CBS News) Milwaukee officials denied the claim by HHS Secretary Robert F. Kennedy Jr. that a lead poisoning team was sent to the city to help. ( CNN)

Two global health groups that fund billions of dollars worth of critical medical aid - from childhood vaccines to malaria treatments - are in talks about merging some functions to help combat a financing crunch,

1️⃣ Grim warning: The world’s ice sheets are on course for runaway melting, leading to multiple feet of sea level rise and “catastrophic” migration. The dire prognosis from a group of international scientists suggests that coastlines will pay the heaviest price .

"Again, I don't want to give advice," Kennedy said. "I can tell you, in Europe, they don't use the chickenpox vaccine specifically because the preclinical trial shows that when you inoculate the population for chickenpox, you get shingles in older people, which is more dangerous."

Gilead is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV resulting from the company’s long-running collaboration with Hookipa Pharma. | Gilead is paying $10 million for sole ownership of arenaviral immunotherapies for hepatitis B (HBV) and HIV resulting from the company’s long-running collaboration with Hookipa Pharma.

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before they ignite a human pandemic. Now, a team of scientists has developed a fresh approach: the first mRNA bird-flu vaccine for cattle.